DE:337's free cash flow for Q was $-7.25M. For the fiscal year, DE:337's free cash flow was decreased by $51.93M and operating cash flow was $-7.25M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Operating Cash Flow	$ -39.79M	$ -48.18M	$ -99.69M	$ -45.72M	$ -30.07M	$ -27.80M
Investing Cash Flow	$ 15.12M	$ -73.42M	$ -484.49K	$ -2.74M	$ -2.30M	$ -707.43K
Financing Cash Flow	$ 1.00	$ 60.82M	$ 154.87M	$ 38.46M	$ 11.42M	$ 76.01M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 122.93M	$ 25.68M	$ 86.45M	$ 31.75M	$ 41.75M	$ 62.70M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	$ 1.84M	$ 1.74M	$ 629.15K	$ 29.45K	$ 10.44K	$ 12.38K
Issuance Of Capital Stock	-	$ 62.59M	$ 142.20M	$ 40.68M	$ 12.05M	$ 78.89M
Issuance Of Debt	$ 984.38K	$ 984.38K	$ 19.67M	$ 963.51K	$ 491.63K	$ 415.26K
Repayment Of Debt	$ -984.37K	$ -926.60K	$ -951.88K	$ -605.53K	$ -434.44K	$ -357.99K
Free Cash Flow	$ -39.86M	$ -48.24M	$ -100.17M	$ -48.46M	$ -32.37M	$ -28.50M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Corbus Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing